Your Location：
Home >
Browse articles >
Biodistribution and pharmacokinetics of 99mTc-CQDO and 99mTc-CQDO-MeB for new myocardial imaging agent
Updated：2021-02-05
Biodistribution and pharmacokinetics of 99mTc-CQDO and 99mTc-CQDO-MeB for new myocardial imaging agent
- Nuclear Science and Techniques Vol.10, Issue 4, (1999)
Published：01 November 1999，
Received：02 April 1999
Scan the full text
Cite this article
0
Views
0
Downloads
0
CSCD
Alert me when the article has been cited
Submit
Tools
Download
Export Citation
Share
Add to favorites
Add to my album
Related Articles
The preclinical pharmacological study of dopamine transporter imaging agent 18F-FP-β-CIT
Preliminary evaluation of the radiotherapeutic efficacy of 131I-atorvastatin in rats with hepatocellular carcinoma
Preparation and biodistribution assessment of 68Ga-DKFZ-PSMA-617 for PET prostate cancer imaging
Synthesis and biological evaluation of 18F-FB-NGA as a hepatic asialoglycoprotein receptor PET imaging agent
Semi-automated synthesis, validation and microPET imaging of 18F-FP-DTBZ as a vesicular monoamine transporter ligand
Related Author
Xiaomin LI
Zhengping CHEN
Songpei WANG
Jie TANG
Yansong LIN
Zhaohui ZHU
Ping FANG
Nourihan S. Farrag
Related Institution
PET Center, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences
Jiangsu Institute of Nuclear Medicine, Key Laboratory of Nuclear Medicine, Ministry of Health
.O. BOX
Research Center for Nuclear Medicine, Shariati Hospital, Tehran University of Medical Sciences
Department of Chemistry, University of Zanjan
0